Friday, July 17, 2026

11:15 AM - 1:15 PM

---

Details

Pharmacogenomics has progressed extensively over the past few decades especially in the discovery sciences and in population diversity having regiospecific clinical implications. Although discovery aspects have been illuminating, the implications for the management of patients have been local and invariably not national. However, over the past few years progress is being made at the national level. This symposium will address clinical implementations programs that have commenced or are commencing in UK, Europe, Africa and, Australia & New Zealand. It will highlight lessons learnt from the initiation and development of programs to their national implementation with shortcomings noted and addressed. This symposium is the initiative of the IUPHAR Pharmacogenetics, Drug Metabolism and Transport Committee.

---

Session chair